AcuteCVDays - Week 1 : Optimal medical treatment following acute coronary syndrome anno 2024
{"name":"AcuteCVDays - Week 1 : Optimal medical treatment following acute coronary syndrome anno 2024", "url":"https://www.quiz-maker.com/QV0FHLU62","txt":"Antithrombotic treatment is an important component of the management of all patients presenting with ACS. The specific choice and combination of therapy, the time of its initiation, and the treatment duration depend on various patient and procedural factors. Which of the following is not included among the antithrombotic therapy recommendations of 2023 ESC ACS Guideline? .quiz-container.quiz-embed {padding: 0!important;} BODY .qp_container{padding: 0!important; margin-top:0!important; margin-bottom: 0!important} .qp_b{max-width:100%;} BODY .qp_bo{max-width:100%;} .qp_t{padding-left:0;} qp_i{margin-right: 10px; margin-bottom: 25px;} .qp_a INPUT[type='radio']{margin-right: 10px; margin-bottom: 25px;} @media only screen and (max-width: 480px){.qp_flex.cf2 .qp_flexc{width: 100%;!important;}}","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}